Brief: LifeTech Scientific Says FDA Approved Investigator-Initiated Clinical Trial Of LAmbre
05/09/2022 01:16
Sept 5 (Reuters) - LifeTech Scientific Corp 1302.HK :
* ON 30 AUGUST GROUP'S LAMBRE TM PLUS LEFT ATRIAL APPENDAGE
CLOSURE SYSTEM OBTAINED MEDICAL INSURANCE COVERAGE IN US
Source text for Eikon: ID:nHKS2jcY3C
Further company coverage: 1302.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeTech Scientific
See all newsBrief: Lifetech Scientific's Ics Elpis Admitted To Nmpa Special Examination On October 19, 2026
Brief: Lifetech Scientific Says Surechamtm Stent Graft Admitted To Nmpa Special Examination And Approval Procedure
Brief: Lifetech Scientific Expects Net Profit Attributable For Six Months Ended June 2026
Brief: Lifetech Scientific To Not Proceed With Major Deal
Brief: Lifetech Scientific To Buy 96.46% Of Starway Medical Technology